Bank of Montreal
BTAI icon

Bank of Montreal’s BioXcel Therapeutics BTAI Stock Holding History

Bank of Montreal’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,957
Closed -$42K – 3879
2024
Q2 		$42K Sell
1,957
-675
-26% -$22.6K ﹤0.01% 3455
2024
Q1 		$120K Sell
2,632
-149
-5% -$7.11K ﹤0.01% 3242
2023
Q4 		$141K Buy
2,781
+118
+4% +$6.56K ﹤0.01% 3276
2023
Q3 		$146K Buy
+2,663
New +$269K ﹤0.01% 3179
2021
Q2 		– Sell
-23
Closed -$13K – 3822
2021
Q1 		$13K Sell
23
-101
-81% -$81.2K ﹤0.01% 4225
2020
Q4 		$101K Buy
124
+90
+265% +$70.1K ﹤0.01% 3574
2020
Q3 		$26K Sell
34
-19
-36% -$14.3K ﹤0.01% 3707
2020
Q2 		$44K Buy
+53
New +$34.6K ﹤0.01% 3492
2020
Q1 		– Sell
-59
Closed -$21.2K – 4139
2019
Q4 		$14K Sell
59
-113
-66% -$11.4K ﹤0.01% 4463
2019
Q3 		$20K Buy
172
+65
+61% +$10.3K ﹤0.01% 4085
2019
Q2 		$19K Buy
107
+31
+41% +$5.25K ﹤0.01% 4199
2019
Q1 		$12K Hold
76
– – ﹤0.01% 3815
2018
Q4 		$5K Buy
76
+1
+1% +$84 ﹤0.01% 4077
2018
Q3 		$9K Buy
75
+74
+7,400% +$11K ﹤0.01% 3943
2018
Q2 		$0 Buy
+1
New +$153 ﹤0.01% 4714

Other funds holding BTAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of Montreal's BTAI Position: Q3 2024 in Review

Bank of Montreal sold out of BioXcel Therapeutics (BTAI) in Q3 2024, closing a stake of 1,957 shares — an estimated $42K sold.

Bank of Montreal first reported a position in BTAI in Q2 2018 and held it in 15 quarters. The position peaked at $146K in Q3 2023. 49 funds tracked by Wall St. Rank hold BTAI as of Q3 2024.

  • Bank of Montreal reported no remaining BioXcel Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 1,957 BioXcel Therapeutics shares in Q3 2024, an estimated $42K.
  • Bank of Montreal first reported a position in BioXcel Therapeutics in Q2 2018 and held it in 15 quarters.
  • Bank of Montreal's BioXcel Therapeutics position peaked at $146K in Q3 2023.
  • 49 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.